Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hib Conjugate Vaccine Phase III in Healthy Infants and Children
NCT02692859Phase 3Completed
- Sponsor
- Jiangsu Provincial Center for Disease Control and Prevention
- Start
- Sep 2013
- Primary completion
- Aug 2014
- Modality
- Split/Subunit Vaccines
01
Overview
Phase 3, randomised, double-blind trial of haemophilus influenzae type b vaccine in Haemophilus influenzae type b infection (Hib) (2 arms), sponsored by Jiangsu Provincial Center for Disease Control and Prevention. Primary endpoints: Number of Participants With Solicited Adverse Reactions and Proportion of Vaccinees With Anti-polyribosylribitol Phosphate (PRP) Concentrations >= 1.0 ug/ml. Started Sep 2013; status: completed.
02
Drugs
haemophilus influenzae type b vaccine
03
Conditions
Haemophilus influenzae type b infection (Hib)
Beyond the preview
Go deeper on NCT02692859.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02692859.